Jakubczyk M - Search Results

1

A framework for sensitivity analysis of decision trees.

Kamiński B, Jakubczyk M, Szufel P. Kamiński B, et al. Among authors: jakubczyk m. Cent Eur J Oper Res. 2018;26(1):135-159. doi: 10.1007/s10100-017-0479-6. Epub 2017 May 24. Cent Eur J Oper Res. 2018. PMID: 29375266 Free PMC article.

2

Cost-effectiveness acceptability curves--caveats quantified.

Jakubczyk M, Kamiński B. Jakubczyk M, et al. Health Econ. 2010 Aug;19(8):955-63. doi: 10.1002/hec.1534. Health Econ. 2010. PMID: 19688780

3

The impact of a belief in life after death on health-state preferences: True difference or artifact?

Jakubczyk M, Golicki D, Niewada M. Jakubczyk M, et al. Qual Life Res. 2016 Dec;25(12):2997-3008. doi: 10.1007/s11136-016-1356-9. Epub 2016 Jul 21. Qual Life Res. 2016. PMID: 27444779

4

The cost-effectiveness of food consistency modification with xanthan gum-based Nutilis Clear® in patients with post-stroke dysphagia in Poland.

Pelczarska A, Jakubczyk M, Niewada M. Pelczarska A, et al. Among authors: jakubczyk m. BMC Health Serv Res. 2020 Jun 17;20(1):552. doi: 10.1186/s12913-020-05411-2. BMC Health Serv Res. 2020. PMID: 32552742 Free PMC article.

5

Economic resources consumption structure in severe hypoglycemia episodes: a systematic review and meta-analysis.

Jakubczyk M, Rdzanek E, Niewada M, Czech M. Jakubczyk M, et al. Expert Rev Pharmacoecon Outcomes Res. 2015;15(5):813-22. doi: 10.1586/14737167.2015.1076338. Epub 2015 Aug 13. Expert Rev Pharmacoecon Outcomes Res. 2015. PMID: 26289736 Review.

6

Cost of severe hypoglycaemia in nine European countries.

Jakubczyk M, Lipka I, Pawęska J, Niewada M, Rdzanek E, Zaletel J, Ramírez de Arellano A, Doležal T, Chekorova Mitreva B, Nagy B, Petrova G, Šarić T, Yfantopoulos J, Czech M. Jakubczyk M, et al. J Med Econ. 2016 Oct;19(10):973-82. doi: 10.1080/13696998.2016.1188823. Epub 2016 Jun 3. J Med Econ. 2016. PMID: 27163169 Free article.

7

[Indirect costs in health technology assessment].

Jakubczyk M, Wrona W, Macioch T, Golicki D, Niewada M, Hermanowski T. Jakubczyk M, et al. Pol Merkur Lekarski. 2010 Jan;28(163):42-5. Pol Merkur Lekarski. 2010. PMID: 20369723 Polish.

8

The impact of firms' adjustments on the indirect cost of illness.

Jakubczyk M, Koń B. Jakubczyk M, et al. Int J Health Econ Manag. 2017 Feb 2. doi: 10.1007/s10754-017-9212-1. Online ahead of print. Int J Health Econ Manag. 2017. PMID: 28154961

9

The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland.

Pelczarska A, Jakubczyk M, Jakubiak-Lasocka J, Banach M, Myśliwiec M, Gruchała M, Niewada M. Pelczarska A, et al. Among authors: jakubczyk m. Atherosclerosis. 2018 Mar;270:132-138. doi: 10.1016/j.atherosclerosis.2018.01.036. Epub 2018 Jan 31. Atherosclerosis. 2018. PMID: 29407882

10

Cost-effectiveness versus Cost-Utility Analyses: What Are the Motives Behind Using Each and How Do Their Results Differ?-A Polish Example.

Jakubiak-Lasocka J, Jakubczyk M. Jakubiak-Lasocka J, et al. Among authors: jakubczyk m. Value Health Reg Issues. 2014 Sep;4:66-74. doi: 10.1016/j.vhri.2014.06.008. Epub 2014 Aug 6. Value Health Reg Issues. 2014. PMID: 29702810 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page